CEO.CA, a leading investor social network for junior resource stocks, released an exclusive interview with Kerem Usenmez, President & CEO of Volta Metals Ltd. The discussion focused on recent assay results and upcoming catalysts at the Springer Rare Earth & Gallium Project in Ontario. CEO.CA connects millions of investors globally and provides insights into emerging mining companies, helping investors stay informed about industry developments and company strategies. This interview is part of CEO.CA's ongoing series 'Inside the Boardroom,' which features executive insights shaping the mining sector's future.
Volta Metals' upcoming gallium resource release is the subject here, with Pluang's Basic Materials sector data providing market context. Of 38 priced Basic Materials-sector US stocks tradable on Pluang, 26 rose and 11 fell today. Notable movers include BHP at USD 86.20 with a 1-day change of +1.92%, Lithium Americas Corp at USD 2.73 up +1.87%, and Agnico Eagle Mines Ltd at USD 187.51 up +1.82%, as of Sep 29, 2026 19:02 WIB.
AT&T and Corning have signed a multi-year agreement worth over $3 billion for Corning to supply fiber and cable to expand AT&T's high-speed internet network. This deal supports AT&T's goal to connect 60 million Americans with fast, reliable fiber int...
A large cryptocurrency whale transferred about 20,000 Ether (ETH), valued at roughly $54.66 million, to the Bitget exchange. The tokens were first converted from stETH to ETH using the 1inch platform before being deposited. Such significant deposits ...
The healthcare sector no longer trades at a discount, with forward price-to-earnings ratios between 16 and 18 times, reflecting more reasonable valuations. The Simplify Health Care ETF (PINK) offers a concentrated, actively managed portfolio position...
Intel's stock has risen over 230% in 2026, driven by strong Q2 revenue growth of 25.4% and robust demand for server CPUs and AI-related products. Despite Wall Street's cautious price target of $116, analysts have raised earnings forecasts for 2027, e...
Appili Therapeutics announced it will voluntarily delist its Class A common shares from the Toronto Stock Exchange (TSX) on October 2, 2026, due to failure to meet TSX's continued listing requirements. The shares will begin trading on the TSX Venture...
